TickerFacts.

Definium Therapeutics, Inc. (DFTX): Shares Outstanding

Annual figures by period end, from SEC filings.

Stock splits: 1-for-15, first reflected in a filing dated 2022-11-10. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

98.78M
As of 2025-12-31
134.37M
As of 2026-06-30
+37.5%
3-year compound annual growth
2021-12-31: 28.13M2022-12-31: 37.98M2023-12-31: 41.10M2024-12-31: 75.10M2025-12-31: 98.78M98.78M
2021-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-3198.78M+31.5%2026-02-26, Balance as of period end
2024-12-3175.10M+82.7%2026-02-26, Balance as of period end
2023-12-3141.10M+8.2%2025-03-06, Balance as of period end
2022-12-3137.98M+35.0%2024-02-28, Balance as of period end
2021-12-3128.13Mn/a2023-03-09, Balance as of period end